MD2876C2 - Биостимулирующее лекарственное средство для локомоторной системы - Google Patents

Биостимулирующее лекарственное средство для локомоторной системы Download PDF

Info

Publication number
MD2876C2
MD2876C2 MDA20040150A MD20040150A MD2876C2 MD 2876 C2 MD2876 C2 MD 2876C2 MD A20040150 A MDA20040150 A MD A20040150A MD 20040150 A MD20040150 A MD 20040150A MD 2876 C2 MD2876 C2 MD 2876C2
Authority
MD
Moldova
Prior art keywords
remedy
biostimulating
locomotor system
embryo
efficient
Prior art date
Application number
MDA20040150A
Other languages
English (en)
Romanian (ro)
Other versions
MD2876B1 (en
Inventor
Христофор ПАНЯ
Original Assignee
Христофор ПАНЯ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Христофор ПАНЯ filed Critical Христофор ПАНЯ
Priority to MDA20040150A priority Critical patent/MD2876C2/ru
Priority to PCT/MD2005/000028 priority patent/WO2006004385A1/ru
Publication of MD2876B1 publication Critical patent/MD2876B1/xx
Publication of MD2876C2 publication Critical patent/MD2876C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Изобретение относится к медицине, а именно к травматологии и предназначено для лечения переломов, псевдоартрозов, посттравматического остеомиелита и дегенеративно-дистрофических заболеваний костно-суставной системы.Сущность изобретения заключается в том, что биостимулирующее лекарственное средство содержит в эффективном количестве первичную тканевую культуру, полученную из локомоторной системы эмбриона свиньи в возрасте 35…39 дней с добавлением 5,5…9,5% от её массы клеток крови эмбриона. Эффективное количество первичных клеток может составлять 50 млн.
MDA20040150A 2004-06-15 2004-06-15 Биостимулирующее лекарственное средство для локомоторной системы MD2876C2 (ru)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MDA20040150A MD2876C2 (ru) 2004-06-15 2004-06-15 Биостимулирующее лекарственное средство для локомоторной системы
PCT/MD2005/000028 WO2006004385A1 (en) 2004-06-15 2005-06-14 Bio-stimulating medicinal agent for locomotor apparatus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20040150A MD2876C2 (ru) 2004-06-15 2004-06-15 Биостимулирующее лекарственное средство для локомоторной системы

Publications (2)

Publication Number Publication Date
MD2876B1 MD2876B1 (en) 2005-10-31
MD2876C2 true MD2876C2 (ru) 2006-07-31

Family

ID=35229977

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20040150A MD2876C2 (ru) 2004-06-15 2004-06-15 Биостимулирующее лекарственное средство для локомоторной системы

Country Status (2)

Country Link
MD (1) MD2876C2 (ru)
WO (1) WO2006004385A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110951894B (zh) * 2020-01-01 2021-03-16 华中农业大学 一种与猪初配日龄性状相关的snp分子标记

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1585G2 (ru) * 2000-05-24 2001-07-31 CIOBANU Pavel Биостимуллирующее средство

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1176896A1 (ru) * 1983-10-17 1985-09-07 Горьковский медицинский институт им.С.М.Кирова Способ хирургического лечени хронического остеомиелита
EP0271668B1 (de) * 1986-10-22 1991-12-18 Gesellschaft für Biotechnologische Forschung mbH (GBF) Wachstumstimulierendes Material, Herstellungsverfahren und therapeutische Zusammensetzung
SU1729500A1 (ru) * 1988-04-26 1992-04-30 Алма-Атинский Государственный медицинский институт Способ костной пластики
RU2225212C2 (ru) * 2001-09-27 2004-03-10 Малахов Олег Алексеевич Способ стимуляции дистракционного регенерата

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1585G2 (ru) * 2000-05-24 2001-07-31 CIOBANU Pavel Биостимуллирующее средство

Also Published As

Publication number Publication date
WO2006004385A1 (en) 2006-01-12
MD2876B1 (en) 2005-10-31

Similar Documents

Publication Publication Date Title
Abd El-Wahed et al. Bee venom composition: from chemistry to biological activity
ECSP055739A (es) Anticuerpos de neutralización contra gdf-8, y sus usos
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
BRPI0414455A (pt) métodos para usar células regenerativas no tratamento de doença vascular periférica e distúrbios afins
MX2007007032A (es) Compuestos de aminopirimidina y metodos de uso.
MX2007004551A (es) Compuestos tiadiazol y metodos de uso.
IL176419A0 (en) An implant for occluding a body passage
NZ606825A (en) Methods and compositions for treating complement-associated disorders
EP2824175A3 (en) Mesenchymal stem cells and uses therefor
ATE489956T1 (de) Formulierungen enthaltend salicylate und deren verwendung zur behandlung von entzündlicher darmerkrankung
NZ597965A (en) Methods of preparing and using stem cell compositions and kits comprising the same
UA81676C2 (ru) Композиция для лечения инфекций у крупного рогатого скота и свиней
BRPI0418157A (pt) terapêutica de tumores alogênicos
NO20070854L (no) Humane monoklonale antistoffer mot humant IL-4.
EP1778186A4 (en) PROCESS FOR PREPARING POLY-ICLC AND USES THEREOF
EP1543158A4 (en) REGULATED APTAMER THERAPEUTICS
EA200600921A1 (ru) Способы и композиции с применением талидомида для лечения и менеджмента рака и других заболеваний
TW200637618A (en) Compositions and methods for treating conditions of the nail unit
MX2008000838A (es) Composiciones y metodos para tratar infeccion bacteriana gram positiva en un sujeto mamifero.
DE60313356D1 (de) Verwendungvon dextransulfat zur behandlung von ibmir
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
MD2876B1 (en) Biostimulating remedy of the locomotor system
ATE464048T1 (de) Behandlung von alzheimer-krankheit und verwandten zuständen
ATE554160T1 (de) Knochenaufbau anhand von vorläuferzusammensetzungen aus muskeln und behandlungen damit
SI1596879T1 (sl) Uporaba spojine kahalalida za pripravo zdravila za zdravljenje luskavice

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees